SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-068487
Filing Date
2020-06-01
Accepted
2020-06-01 17:22:18
Documents
5
Period of Report
2020-05-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2019073-8_8k.htm 8-K 20202
2 EXHIBIT 1.1 tm2019073d8_ex1-01.htm EX-1.1 223913
3 EXHIBIT 5.1 tm2019073d8_ex5-1.htm EX-5.1 7327
4 GRAPHIC tm2019073d8_ex5-1img001.jpg GRAPHIC 12278
5 EXHIBIT 99.1 tm2019073d8_ex99-1.htm EX-99.1 6072
  Complete submission text file 0001104659-20-068487.txt   275811
Mailing Address 840 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address 840 MEMORIAL DRIVE CAMBRIDGE MA 02139 617-498-0020
Mersana Therapeutics, Inc. (Filer) CIK: 0001442836 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38129 | Film No.: 20934677
SIC: 2834 Pharmaceutical Preparations